Källenius G - Search Results

1

Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.

Hamasur B, Haile M, Pawlowski A, Schröder U, Williams A, Hatch G, Hall G, Marsh P, Källenius G, Svenson SB. Hamasur B, et al. Among authors: kallenius g. Vaccine. 2003 Sep 8;21(25-26):4081-93. doi: 10.1016/s0264-410x(03)00274-3. Vaccine. 2003. PMID: 12922145

2

Mycobacterial glycoconjugates as vaccine candidates against tuberculosis.

Källenius G, Pawlowski A, Hamasur B, Svenson SB. Källenius G, et al. Trends Microbiol. 2008 Oct;16(10):456-62. doi: 10.1016/j.tim.2008.07.007. Epub 2008 Sep 4. Trends Microbiol. 2008. PMID: 18774297

3

Recent developments in tuberculosis vaccines.

Haile M, Källenius G. Haile M, et al. Among authors: kallenius g. Curr Opin Infect Dis. 2005 Jun;18(3):211-5. doi: 10.1097/01.qco.0000168380.08895.9a. Curr Opin Infect Dis. 2005. PMID: 15864097 Review.

4

A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines.

Pawlowski A, Källenius G, Svenson SB. Pawlowski A, et al. Among authors: kallenius g. Vaccine. 1999 Mar 17;17(11-12):1474-83. doi: 10.1016/s0264-410x(98)00385-5. Vaccine. 1999. PMID: 10195784

5

Synthesis and immunologic characterisation of Mycobacterium tuberculosis lipoarabinomannan specific oligosaccharide-protein conjugates.

Hamasur B, Källenius G, Svenson SB. Hamasur B, et al. Among authors: kallenius g. Vaccine. 1999 Jul 16;17(22):2853-61. doi: 10.1016/s0264-410x(99)00124-3. Vaccine. 1999. PMID: 10438056

6

Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.

Pawlowski A, Källenius G, Svenson SB. Pawlowski A, et al. Among authors: kallenius g. Vaccine. 2000 Mar 17;18(18):1873-85. doi: 10.1016/s0264-410x(99)00336-9. Vaccine. 2000. PMID: 10699336

7

Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.

Haile M, Schröder U, Hamasur B, Pawlowski A, Jaxmar T, Källenius G, Svenson SB. Haile M, et al. Among authors: kallenius g. Vaccine. 2004 Mar 29;22(11-12):1498-508. doi: 10.1016/j.vaccine.2003.10.016. Vaccine. 2004. PMID: 15063575

8

A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Hamasur B, Haile M, Pawlowski A, Schroder U, Kallenius G, Svenson SB. Hamasur B, et al. Among authors: kallenius g. Clin Exp Immunol. 2004 Oct;138(1):30-8. doi: 10.1111/j.1365-2249.2004.02593.x. Clin Exp Immunol. 2004. PMID: 15373902 Free PMC article.

9

Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.

Haile M, Hamasur B, Jaxmar T, Gavier-Widen D, Chambers MA, Sanchez B, Schröder U, Källenius G, Svenson SB, Pawlowski A. Haile M, et al. Among authors: kallenius g. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):107-14. doi: 10.1016/j.tube.2004.09.013. Epub 2005 Jan 20. Tuberculosis (Edinb). 2005. PMID: 15687034

10

Should a new tuberculosis vaccine be administered intranasally?

Källenius G, Pawlowski A, Brandtzaeg P, Svenson S. Källenius G, et al. Tuberculosis (Edinb). 2007 Jul;87(4):257-66. doi: 10.1016/j.tube.2006.12.006. Epub 2007 Feb 26. Tuberculosis (Edinb). 2007. PMID: 17321797 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters